IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Transplant-Related Hematologic Malignancy
IRCCS San Raffaelemonoclonal_antibodyPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Transplant-Related Hematologic Malignancy cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Treosulfan IRCCS San Raffaele | Phase 2 | BB |
Fludarabine IRCCS San Raffaele | Phase 2 | B |
Cytosin-Arabinosid Ciceri Fabio | Phase 2 | B |
Thiotepa Ciceri Fabio | Phase 2 | B |
Revumenib Center for International Blood and Marrow Transplant Research | Phase 2 | CCC |
View all 10 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →